KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Common Equity (2016 - 2025)

Historic Common Equity for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $28.2 billion.

  • Cme's Common Equity fell 9.18% to $28.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $28.2 billion, marking a year-over-year decrease of 9.18%. This contributed to the annual value of $26.5 billion for FY2024, which is 93.87% down from last year.
  • Latest data reveals that Cme reported Common Equity of $28.2 billion as of Q3 2025, which was down 9.18% from $27.7 billion recorded in Q2 2025.
  • Over the past 5 years, Cme's Common Equity peaked at $28.3 billion during Q3 2022, and registered a low of $26.5 billion during Q4 2024.
  • For the 5-year period, Cme's Common Equity averaged around $27.4 billion, with its median value being $27.4 billion (2021).
  • Examining YoY changes over the last 5 years, Cme's Common Equity showed a top increase of 453.31% in 2022 and a maximum decrease of 190.0% in 2022.
  • Cme's Common Equity (Quarter) stood at $27.4 billion in 2021, then fell by 1.9% to $26.9 billion in 2022, then dropped by 0.52% to $26.7 billion in 2023, then fell by 0.94% to $26.5 billion in 2024, then rose by 6.43% to $28.2 billion in 2025.
  • Its Common Equity stands at $28.2 billion for Q3 2025, versus $27.7 billion for Q2 2025 and $27.0 billion for Q1 2025.